MENU
GLPG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Galapagos (GLPG) Ownership - Who owns Galapagos?
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Generaal De Wittelaan L11 A3
Phone
+32 15342900
Employees
1123
Web
https://www.glpg.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.72B
P/E Ratio
53.70
Total Cash
3.3B
Projected Growth
N/A
Total Debt
10.86M
Revenue
288.19M
Risk (Beta)
0.34
Dividend Yield
N/A
Total Cash/Share
50.04
Total Debt/Equity
N/A
Revenue/Share
4.95 USD as % of share price
Fundamentals
GLPG
Capitalization
1.72B
P/E Ratio
53.70
Risk (Beta)
0.34
Dividend Yield
N/A
Total Cash
3.3B
Total Cash/Share
50.04
Total Debt
10.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.95%
Revenue
288M
ROE
N/A
Book Value
2.75B
P/B Ratio
0.56
Cash Flow
N/A
Earnings
-2.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
294M
Current Ratio
7.95
Current Revenue Per Employee
106501.42
Dividends Per Share - Security
N/A
EBITDA
-127.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.69
Revenue To Assets
-4.04
Shares Held By Institutions
437M
Shares Outstanding - Current
65.9M
Total Liabilities
1.27B
Total Volume MTD
N/A
Value
-1
Gain YTD
-7.273
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Generaal De Wittelaan L11 A3
Phone
+32 15342900
Employees
1123
Web
https://www.glpg.com